OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

← The Prostate Project

2024-06-30-accounts

THE PROSTATE PROJECT

UNAUDITED REPORT AND FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 JUNE 2024

CHARITY NO: 1078523

Moore (South) LLP

Chartered Accountants Suite 3, Second Floor Friary Court 13-21 High Street Guildford Surrey GU1 3DG

THE PROSTATE PROJECT

CONTENTS

Page
Legal and Administrative Information 1
Report of the Trustees 2 - 10
11
Statement of Financial Activities 12
Balance Sheet 13
Notes to the Accounts 14 - 24

THE PROSTATE PROJECT LEGAL AND ADMINISTRATIVE INFORMATION FOR THE YEAR ENDED 30 JUNE 2024

Page 1

TRUSTEES H J Turner (Chairman - resigned 31/12/23)
A Boden (appointed 21/3/24)
A Bolton
S R J Bott
M Collins (appointed 21/3/24)
C Critchlow (appointed 21/3/24)
M Davies (appointed trustee 21 September 2023;
appointed chairman 01/01/2024)
Prof S Langley
Prof H Pandha
S McGuire (appointed 21/3/24)
C Perna
M Perry
T J Sharp (resigned 21/11/23)
V Simmons (died January 2024)
Sqn Ldr R C Smith (resigned 27/11/23)
M H Swaden (resigned 21/9/ 2023)
D Whitby
A Wootton (appointed 21/3/24)
PRESIDENT T J Sharp (died December 2024)
AMBASSADOR C Stokes
PATRONS J Alliss
The Bishop of Guildford
C Brumpton
M Buerk
H McGrath
V Hamilton
K Jones
F Kendall
A Milton
L Spaine
R Thompson
CHARITY REGISTRATION NUMBER 1078523
PRINCIPAL OFFICE Stokes Centre for Urology
Royal Surrey County Hospital
Egerton Road
Guildford
Surrey GU2 7XX
INDEPENDENT EXAMINER Matthew Bather ACA
Moore (South) LLP
Chartered Accountants
Suite 3, Second Floor, Friary Court
13-21 High Street
Guildford
Surrey GU1 3DG

BANKERS CURRENT ACCOUNT CafCash HSBC 25 Kings Hill Avenue 110 High Street Kings Hill Godalming West Malling Surrey Kent ME19 4JQ GU17 1DP

THE PROSTATE PROJECT REPORT OF THE TRUSTEES FOR THE YEAR ENDED 30 JUNE 2024

Page 2

The Trustees present their report and the financial statements for the year ended 30 June 2024.

GOVERNING DOCUMENT

The organisation is an unincorporated trust, constituted under a Trust Deed dated 9 December 1999 and is a registered charity, number 1078523.

TRUSTEES

The Trustees who served from 1 July 2023 to 30 June 2024 are set out on page 1.

RECRUITMENT AND APPOINTMENT OF TRUSTEES

The Board of Trustees is responsible for the recruitment and appointment of Trustees. The Board seeks to ensure that they have the requisite skills between them to run the charity.

TRUSTEE INDUCTION AND TRAINING

Most new Trustees are already familiar with the practical work of the organisation.

New Trustees are given a short, informal training session to familiarise themselves with the charity and the context within which it operates. This covers:

AIMS AND OBJECTIVES

The principal objectives of the charity are:

THE PROSTATE PROJECT REPORT OF THE TRUSTEES FOR THE YEAR ENDED 30 JUNE 2024

Page 3

AIMS AND OBJECTIVES (continued)

This should be achieved at the lowest administrative cost which sets us apart from the other charities operating in this sector. In this respect, the charity is largely run by volunteers with no offices and low staff costs to fund. As a result, we are likely to be the most cost-effective charity operating in this sector.

SUMMARY OF PUBLIC BENEFITS

Prostate Cancer is the number one cancer in men in the UK. The overall role of the Prostate Project as a charity is to raise and provide funds and resources across a range of initiatives to fight, prevent and eventually eliminate this disease.

The activities of the Prostate Project are in accordance with the Charity Commission's guidance on public benefit. Our objectives and achievements primarily benefit men above the age of 45 although our work on cancer research also has a spin off on younger strategy focuses on six key objectives on prostate cancer as outlined below:

1. Raising awareness

The Prostate Project is determined to continue its work to raise public awareness of prostate cancer to promote early diagnosis through briefings and communications to local organisations, as well as using the internet, social media, and more traditional means of information boards in public places such as libraries and shopping centres. The Prostate Project also publishes and distributes local information leaflets and booklets with content freely available on its web site. Although men are the main target audience, we know that women have a vital role in helping their partners, fathers and sons in coming forward and overcoming natural reluctance on sensitive health matters. A further challenge are ethnic minorities and low-income groups understanding that they have a much higher risk of prostate cancer, especially black men where there is double the incidence rate of them in understanding new developments in diagnosis and treatment as well as the support we can offer their patients.

2. Early Detection PSA Testing

Early detection is key with all cancers, and especially prostate cancer when there are often no visible symptoms of the disease. The Charity actively encourages and supports PSA (ProstateSpecific Antigen) testing in men aged 45 to 70 to ensure early diagnosis. This should be undertaken in a proper regulated clinical environment in accordance with the highest NHS and Care Quality Commission (CQC) standards. Unfortunately, there are still occasions where men may find it difficult to obtain a PSA from their GP, so in these instances we support their right to have the test outlined below, is the provision of mobile PSA blood testing vehicle. This will ensure not only routine PSA testing but will also target the missing hospital referrals due to the large numbers of men who did not come forward during the pandemic, as well as low income and ethnic groups.

THE PROSTATE PROJECT REPORT OF THE TRUSTEES FOR THE YEAR ENDED 30 JUNE 2024

Page 4

3. Research and Development

Another goal is the creation of a world class clinical based research centre focused on new methods of early diagnosis and treatment, especially of advanced prostate cancer, and to better understand the genetic and ethnic issues of the disease. This should also be undertaken in collaboration where University of Surrey in 2006. Some of the developments produced by the 25 strong team have shown relevance for detection and treatment of other cancers. In particular, much of this research is highly advanced and uses new technologies such as immunotherapy. Support from the Charity is provided in funding for research posts, laboratory equipment and research trials.

4. Medical Equipment, Staff and Facilities for local hospitals

A major aim was achieved 5 years ago when the Stokes Centre for Urology was opened at the Royal Surrey NHS Foundation Trust in Guildford, which the Charity half funded at £2.6m. This provides a best in class outpatients and day treatment facility for both NHS and private patients, with additional space for research and administrative duties. We have also funded both Royal Surrey and Frimley Park hospitals with medical equipment where this would not normally be provided by the NHS. An example would be the donation of a £125,000 Echolaser to treat benign prostate hyperplasia (BPH), thereby freeing up hospital resources to treat more urgent cases. Royal Surrey is one of the few hospitals to offer this same-day treatment. Funding has also been provided in the past for specialist roles such as nurses and research administrative staff.

5. Support for Men with Prostate Cancer and their families

We run a support group, which is accessible to anyone, to offer fellowship and support, in the form of meetings and one-to-one discussions, to men suffering from prostate cancer and their partners and families. It is vital to encourage the public to talk about prostate cancer more freely and for men to visit their GP promptly if they have concerns.

6. Funding for the above

Our fundraising committee works at all levels to drive funding to support the strategic objectives and projects for each year. This includes individual donations to working with local organisations (e.g. golf clubs, Lions, and Masons) who run Our members have always been very generous in providing donations to specific causes both of their own accord and when we request funds. Major events also take an increasing role especially concerts such as at G Live in Guildford which raise a significant contribution and where we can make maximum impact on our prostate cancer awareness messaging. We also have benefitted from corporate sponsorship which continues with renewed focus.

This is because we are mainly staffed by volunteers with only one paid part time administrator and specialized contractors for support on such items as information technology and communications.

ACCOUNTING PRINCIPLES

The accounts have been prepared in accordance with the Statement of Recommended Practice on the basis of the accounting policies set out on pages 14 - 16.

THE PROSTATE PROJECT REPORT OF THE TRUSTEES FOR THE YEAR ENDED 30 JUNE 2024

Page 5

REVIEW OF PROGRESS, ACHIEVEMENTS AND FUTURE OBJECTIVES

This section of the report provides a summary of the highlights and key activities of the Prostate Project over the last 12 months. It reviews progress and records achievements over that period as well as outlining objectives for next year.

2023-24 KEY ACHEIVEMENTS AND HIGHLIGHTS

  1. The Mobile PSA Testing Clinic, or "Man Van", was delivered at the end of June 2024. The plan was for the Charity to cover the cost of the vehicle and for our NHS partners to fund the ongoing running costs. Fund raising commenced in January 2022 and by the following August we had raised the costs of the van to allow placing of the order. The delay in the delivery of the van meant that NHS funding for operational costs was no longer available from February 2024, so we are currently in discussions with our NHS partners on the support we can provide, together with a medical company and two prostate cancer testing charities. The vehicle will be one of the first of its kind, testing many men a year and specifically reducing inequality by targeting low income and ethnic groups which suffer higher incidence of prostate cancer. As the plan is for it to operate in both a regulated NHS environment where it will have direct referral to hospital consultation which will speed up clinical pathway which is vital for cancer diagnosis and treatment and in an unregulated charity-led environment.

  2. This was the second year of 3 year formal agreement with the University of Surrey to fund research activity is now in place rather than the previous ad hoc arrangement. This allows both the Charity and the University to better plan initiatives. The Charity also funded equipment, consumables and PhD student posts. The activities of the Research team are focussed on 3 main areas: Improved diagnosis; Treatment of Advanced Prostate Cancer; and the reasons behind racial variations in the incidence of the disease. The Research team also contributed to fundraising with an Art Auction and 50km ultra challenges.

  3. at G Live in Guildford in early January. As in the previous year we raised over £60,000 over two nights. Special thanks are due to Paul Jones and the artists involved, including Andy Fairweather-Low and Jimmy Helms, as well as our long-term supporter, Tony Smith from Eclectic Live Music for organising and promoting the event. We also showed our new awareness animation on the risks of prostate cancer. Planning for G Live in early 2025 is already underway.

  4. Golf events continue to be a major fund raising opportunity. We are highly thankful for the continuing support from Univar and their golf day at the Belfry raised over £30,000. r Jock Allen

day. Thanks are also due to West Surrey Golf Club, Cranleigh Golf Club, and Hartley Wintney Golf Club which all made us their charity of the year. Receipts from these events will feature in next year's report. We also held a special golf day to honour the memory of our Patron and BBC presenter, Peter Alliss, at Haselmere Golf Course which raised approximately £6,000.

THE PROSTATE PROJECT REPORT OF THE TRUSTEES FOR THE YEAR ENDED 30 JUNE 2024

Page 6

2023-24 KEY ACHEIVEMENTS AND HIGHLIGHTS (continued)

  1. There were numerous other fund raising events and activities in the year. It is not possible to mention them all but we thank each and everyone involved, big or small, group or individual. However, three major events stand out which were the Charity Art Auction, tribute gig for Roger Nicklin and a dinner with our Patron, Michael Buerk.

  2. We also reviewed and have now re-launched our Support Group activities. The new Support well being during and following prostate cancer treatment. This is run by Andrew Gabriel.

The fact that the Charity is mainly run by volunteers also ensures costs are maintained at a low level with a very high proportion of donations being passed through to projects with benefit men with prostate cancer.

Overall, we are incredibly grateful to our members and supporters for keeping up and in many cases increasing their donations in these challenging times with the cost of living crisis. A special note of thanks must be made to the ongoing and wonderful financial support of individuals, family trusts and companies who share our goals and ambitions.

PROGRESS REPORT AGAINST OBJECTIVES FOR 2023-24

Aims and objectives for the financial year are set out below.

1. General

2. Awareness of Prostate Cancer & Early Diagnosis:

3. Hospitals

THE PROSTATE PROJECT REPORT OF THE TRUSTEES FOR THE YEAR ENDED 30 JUNE 2024

Page 7

4. Research

The prostate cancer research programme has progressed well. A major research focus has been undertaken by a PhD student who was joint funded by the Prostate Project and the University of Surrey; investigating the racial disparity in clinical outcomes in men with prostate cancer, focusing on the role of the tumour microbiome and its influence on the immune microenvironment in prostate cancers. Through collaboration with urology colleagues at North Bristol NHS Trust, The Royal Marsden and our own centre at the Royal Surrey NHS Foundation Trust, a cohort of 114 prostatectomy specimens from patients of different ethnicities have been collected. These specimens have all been genotyped to accurately establish patient ancestry and dissected areas of tumour-enriched and normal-adjacent tissue sequenced for profiling the microbial signatures. The bioinformatic analysis of this is currently on-going. Alongside this the research team has had a fruitful collaboration with Miltenyi Biotec which has given them access to their MACSima Imaging Platform to investigate the immune response within prostate cancer specimens from Black-African, Black-Caribbean, Asian and White patients. All optimisation of the immune marker panel for highplex immunofluorescent (mIF) analysis is now complete and this analysis will now be applied to the cohorts of ethnic prostate cancer tissues. Upon completion of these investigations, the relationships between microbial communities within intraprostatic niches and the associated tumour immune microenvironment, coupled with patient clinical data, will reveal the complex biology potentially underpinning ethnic disparity in prostate cancer clinical outcomes.

A second research project utilising state-of-the-art technology is using an approach called GeoMx Digital Spatial Profiling (DSP) to understand the immune microenvironment of Neuroendocrine Prostate Cancer (NEPC). Using 5 NEPC and 5 prostate adenocarcinoma specimens this assay was conducted at the Blizard Institute, Queen Mary University of London. Specific regions of interest from each of the biopsies were selected for analysis and the bioinformatic analysis of this data is currently underway. This project is also in collaboration with a research team at the Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

The same technology as above (GeoMxDSP) is also being utilised to understand the immune response underlying the therapeutic response to a novel triple combination immunotherapy utilising - which was conducted in a prostate cancer in vivo model. The results of this will benefit the plans to develop a vaccine strategy funded by the Prostate Project to prevent cancer from returning in men who have had surgery to remove their prostate. The planned approach uses a new cancer-killing virus (HSV5-15) developed at the University of Surrey, which strengthens the immune response against tumours.

Research focused on development of new prostate cancer targeting drugs (androgen receptor pathway inhibitors (ARPI)), has resulted in the development of novel, first-in-class inhibitors targeting the oncogenic pathways that inhibit Castration-Resistant Prostate Cancer (CRPC) growth in preclinical models where Enzalutamide fails. These drug discoveries will provide renewed hope to CRPC patients who normally have very limited targeted treatment options.

THE PROSTATE PROJECT REPORT OF THE TRUSTEES FOR THE YEAR ENDED 30 JUNE 2024

Page 8

4. Research (continued)

Publications from the last year are below:

Other Key Items

There have been many other items progressed and as Chairman I would like to give special thanks to the following for their contributions to the work of the Charity.

Long term support:

Former Chairman and now Ambassador, Colin Stokes, and long term Honorary President, Tim Sharp for their continued support and advice over the last year. Also I would like to thank Vic Simmons, who sadly died in January 2024, for his continued support over many years. Lastly, and by no means least, I would like to thank Alf Turner for his transformational role as Chairman of the Prostate Project.

Gift Aid

We are indebted to Robin Smith for the work he does to ensure we are able to reclaim the gift aid on qualifying donations. This totalled £12,509 (2023 - £11,958) this year.

Publicity

Ian Blyth from C&M Marketing continues to support publicity and communications. We thank him, his associate Twiz Kay, and our own administrator, Katherine Hammersley for their hard work in supporting the charity.

Financial matters within the Charity

Andrew Bolton continues as Treasurer and Trustee. We thank him for his excellent financial advice and stewardship.

THE PROSTATE PROJECT REPORT OF THE TRUSTEES FOR THE YEAR ENDED 30 JUNE 2024

Page 9

CHARITY OBJECTIVES FOR 2024-25

priorities for the new financial year:

REVIEW OF FINANCIAL ACTIVITIES

During the year the charity received donations and legacies of 311,614 (2023 - £354,076), income from trading activities of £13,920 (2023 - £1,811) and investment income of £14,147 (2023 - £3,345). Costs for raising funds totalled £32,414 (2023 - £35,372). Charitable activities costs of £295,092 (2023 - £326,746) and other costs were £4,685 (2023 - £4,512).

As a result, the charity had net incoming resources for the year of £7,490 (2023 outgoing resources of £7,398).

The total unrestricted balance carried forward at 30 June 2024 was a surplus of £146,175 (2023 £138,685). These Grants Funds are unrestricted funds which can be utilised at the discretion of the Trustees as long as they are spent within the restrictions of the Charity.

GRANTS POLICY

The Trustees only commit to a grant once they know they have received sufficient funding to cover the specific project. This is key to protecting both the Trustees and the long-term funding commitments made by the charity.

RESERVES POLICY

The Trustees aim to keep cash reserves covering six months support expenditure, which is approximately £20,000. Any reserves over and above that are available to give as grants.

THE PROSTATE PROJECT REPORT OF THE TRUSTEES FOR THE YEAR ENDED 30 JUNE 2024

Page 10

ORGANISATIONAL STRUCTURE

The day to day running of the charity is undertaken by the Trustees and the wide Prostate Committee. The Trustees are responsible for the strategic direction and policy of the charity and meet as regularly as necessary. The Trustees provide their time for the day to day running of the charity on a voluntary basis.

RISK

The major risks to which the charity is exposed, as identified by the Trustees, have been reviewed and systems or procedures have been established to manage those risks.

in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

The law applicable to charities in England & Wales requires the trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charity and of the incoming resources and application of resources of the charity for that period. In preparing these financial statements, the trustees are required to:

The Trustees are responsible for maintaining proper accounting records which disclose with reasonable accuracy at any time the financial position of the charity and enable them to ensure that the financial statements comply with the Charities Act 2011, the Charities (Accounts and Reports) Regulations 2008 and the provisions of the trust deed. They are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

10th February 2025 Approved by the Board of Trustees on ................05 and signed on their behalf by:

Martin Davies

INDEPENDENT EXAMINER’S R EPORT TO THE TRUSTEES OF THE PROSTATE PROJECT FOR THE YEAR ENDED 30 JUNE 2024

Page 11

I report to the charity’s trustees on my examination of the accounts of the charity for the year ended 30 June 2024 which are set out on pages 12 to 24.

Responsibilities and basis of report

accordance with

Act and in carrying out my examination I have followed all the applicable Directions given by the Charity Commission under section 145(5)(b) of the Act.

listed in Section 145 of the Act. I confirm that I am qualified to undertake the examination because I am a member of the ICAEW.

I have completed my examination. I confirm that no materials matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:

  1. accounting records were not kept in respect of the charity as required by section 130 of the Act; or

  2. the accounts do not accord with those records; or

  3. the accounts do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a ‘true and fair view’ which is not a matter considered as part of an Independent Examination.

  4. matter

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.

................................................. Matthew Bather ACA Moore (South) LLP Chartered Accountants Suite 3, Second Floor Friary Court 13-21 High Street Guildford Surrey, GU1 3DG

6th March 2025 ............................................... Date

THE PROSTATE PROJECT STATEMENT OF FINANCIAL ACTIVITIES (INCLUDING INCOME & EXPENDITURE ACCOUNT) FOR THE YEAR ENDED 30 JUNE 2024

Page 12

Total Total
Notes Unrestricted Restricted Funds Funds
2024 2023
£ £ £ £
INCOMING RESOURCES
Donations and legacies 3 254,362 57,252 311,614 354,076
Other trading activities 4 13,920 - 13,920 1,811
Investment income 14,147 - 14,147 3,345
--------- --------- --------- ---------
Total Incoming Resources 282,429 57,252 339,681 359,232
===== ===== ===== =====
RESOURCES EXPENDED
Raising funds 5 32,414 - 32,414 35,372
Charitable activities 6 237,840 57,252 295,092 326,746
Other 9 4,685 - 4,685 4,512
--------- --------- --------- ---------
274,939 57,252 332,191 366,630
===== ===== ===== =====
Net outgoing resources
and net movement in funds 7,490 - 7,490 (7,398)
--------- --------- --------- ---------
Reconciliation of funds 7,490 7,490 (7,398)
Total funds brought forward 138,685 12,543 151,228 158,626
--------- --------- --------- ---------
Total funds carried forward 16 146,175 12,543 158,718 151,228
===== ===== ===== =====

The financial statements include all gains and losses in the period.

The notes on pages 14 to 24 form part of these financial statements.

THE PROSTATE PROJECT BALANCE SHEET AS AT 30 JUNE 2024

Page 13

30 June 30 June 30 June 30 June
2024 2024 2024 2023
Unrestricted Restricted Total Total
Notes Funds Funds
£ £ £ £
Current assets
Cash at bank 12 422,483 42,289 464,772 562,928
--------- --------- --------- ---------
422,483 42,289 464,772 562,928
===== ===== ===== =====
Creditors falling due
within one year
Grants payable within one year 13 255,657 29,746 285,403 366,501
Accruals 13 20,651 - 20,651 21,199
--------- --------- --------- ---------
276,308 29,746 306,054 387,700
===== ===== ===== =====
Total assets less current liabilities 146,175 12,543 158,718 175,228
Creditors falling due
after one year
Grants payable 14 - - - 24,000
--------- --------- --------- ---------
Net assets 146,175 12,543 158,718 151,228
===== ===== ===== =====
Unrestricted funds 16 146,175 - 146,175 138,685
Restricted funds 16 - 12,543 12,543 12,543
--------- --------- --------- ---------
Total Funds 146,175 12,543 158,718 151,228
===== ===== ===== =====

These financial statements were approved by the Trustees on 10th February 2025 and are signed on their behalf by:

Martin Davies

The notes on pages 14 to 24 form part of these financial statements.

THE PROSTATE PROJECT NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2024

Page 14

1. ACCOUNTING POLICIES

a. Charity Status

The charity is governed by a Trust Deed dated 9 December 1999. The charity was registered with the Charity Commission on that date, registered number 1078523. The address of the principal office is given in the Legal & Administration Information given on page 1 of these financial statements.

The charity contributes a public benefit as defined by FRS 102.

b. Basis of Preparation

The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102), Charities SORP 2019 (FRS102), and the Charities Act 2011.

The financial statements are prepared on a going concern basis under the historical cost convention. The financial statements are prepared in sterling which is the functional currency, and have been rounded to the nearest pound.

c. Going Concern

The financial statements have been prepared on a going concern basis as the Trustees believe that no material uncertainties exist. The Trustees have considered the level of funds held and the expected level of income and expenditure for the 12 months from authorising these financial statements. The budgeted income and expenditure in addition to existing reserves is sufficient to fund the going concern.

d. Income Recognition

All incoming resources are included in the Statement of Financial Activities (SoFA) when the charity is legally entitled to the income, the amount can be reliably measured and it is probable that the income will be received.

Donations and other forms of voluntary income are recognised when receivable by the charity. They are typically received from former patients or from individuals who have read the newsletter. When particular needs are identified for a specific project approaches are made to local supporters of the charity, who may then make donations towards that specific project.

The income from charitable activities is recognised when it is received.

Gift aid is recognised in the period the donation it relates to was received.

Income from other trading activities is recognised when it is received.

THE PROSTATE PROJECT NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2024

Page 15

1. ACCOUNTING POLICIES (continued)

e. Donation of Gifts and Services

Donated gifts and professional services are recongised as income when the charity has control over the item or received the service, any conditions associated with the donation have been met, the receipt of economic benefit from the use by the charity of the item is probable and that economic benefit can be measured reliably.

On receipt, donated gifts and professional services are recognised on the basis of the value of the gift to the charity, which is the amount the charity would have been willing to pay to obtain services or facilities of equivalent economic benefit on the open market; a corresponding amount is then recognised in expenditure in the period of receipt.

No value is given to the donations which are given for subsequent auction as prizes at events due to difficulty, in many cases, of establishing a fair value of the donation.

f. Expenditure Recognition

All expenditure is accounted for on an accruals basis and is inclusive of irrecoverable VAT. Expenditure is recognised where there is a legal or constructive obligation to make payments to third parties, it is probable that the settlement will be required and the obligation can be measured reliably.

Other costs include costs that are neither related to raising funds for the charity, nor part of its expenditure on charitable activities.

g. Support Costs

Support costs are those costs incurred in running the charity, but do not directly relate to either raising funds or charitable activities. These costs have been allocated to raising funds and charitable activities, on the bases set out in note 7.

h. Debtors

Trade and other debtors are recorded at settlement amount. Prepayments are valued at the amounts prepaid at balance sheet date.

i. Cash at Bank and in Hand

Cash at bank and in hand includes cash and short term highly liquid investments with short maturity of three months or less from the date of acquisition or opening of the deposit or similar account.

THE PROSTATE PROJECT NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2024

Page 16

j. Creditors

Trade and other creditors are recognised when the charity has a present obligation resulting from past events and can be measured or estimated reliably. Creditors are recognised at their settlement amounts.

k. Financial Instruments

The trust only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value.

l. VAT and Income Tax

The charity is not VAT registered and is exempt from income tax.

m. Funds

Unrestricted reserves are funds that can be used in accordance with the charitable objects at the discretion of the Trustees.

Designated funds are funds that at the end of each year the Trustees may set aside for any specific projects they wish to fund.

Restricted reserves are funds that can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes.

2. Judgements and Key Sources of Estimation Uncertainty

make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

The Trustees do not believe there are any judgements or estimates.

THE PROSTATE PROJECT NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2024

Page 17

3. DONATIONS AND LEGACIES

Unrestricted Restricted Total Total
2024 2023
£ £ £ £
Donations 239,623 57,252 296,875 348,076
Legacies 14,739 - 14,739 6,630
--------- --------- --------- ---------
Total 254,362 57,252 311,614 354,706
===== ===== ===== =====

There was £62,076 of restricted donations received in 2023.

4. OTHER TRADING ACTIVITIES

Unrestricted Restricted Total Total
2024 2023
£ £ £ £
Fundraising events 13,920 - 13,920 1,811
===== ===== ===== =====

There was no restricted income in 2023 from other trading activities.

5. RAISING FUNDS

AISING FUNDS
Unrestricted Restricted Total Total
2024 2023
£ £ £ £
General
Direct costs 12,210 - 12,210 4,821
Support costs (note 7) 20,204 - 20,204 30,551
--------- --------- --------- ---------
Total 32,414 - 32,414 35,372
===== ===== ===== =====

There were no restricted support costs in 2023.

6. CHARITABLE EXPENSES

Unrestricted Restricted Total Total
2024 2023
£ £ £ £
Grants payable (note 8) 237,840 57,252 295,092 326,746
===== ===== ===== =====

In 2023 there were restricted grants of £62,076.

THE PROSTATE PROJECT NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2024

Page 18

7. SUPPORT COSTS

Basis Unrestricted Restricted Total Total
2024 2023
£ £ £ £
Printing and website Income 8,198 - 8,198 18,938
PR costs Income 9,780 - 9,780 8,250
Other costs Income 2,226 - 2,226 3,363
--------- --------- --------- ---------
Total support costs 20,204 - 20,204 30,551
===== ===== ===== =====

There were no restricted support costs in 2023.

8. ANALYSIS OF GRANTS PAYABLE

Unrestricted Restricted Total Total
2024 2023
Man Van - 20,000 20,000 112,795
Probe - - - 7,875
Echolaser 102,600 - 102,600 -
Incucyte 11,737 - 11,737 -
Laser 10,000 - 10,000 -
--------- --------- --------- ---------
Total Grants to Institutions 124,337 20,000 144,337 120,670
===== ===== ===== =====
Unrestricted Restricted Total Total
2024 2023
£ £ £ £
SCR1 - W Hobby 26,000 - 26,000 21,000
K Hammersley 26,000 - 26,000 35,000
M Hammill - - - 48,000
PHD Smith - 37,252 37,252 27,076
M Perry 49,976 - 49,976 75,000
C Perna 32,527 - 32,527 -
--------- --------- --------- ---------
Total Grants to Individuals 134,503 37,252 171,755 206,076
Grants written back (21,000) - (21,000) -
===== ===== ===== =====
Total Grants Payable 237,840 57,252 295,092 326,746
===== ===== ===== =====

THE PROSTATE PROJECT NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2024

Page 19

8. ANALYSIS OF GRANTS PAYABLE (continued)

Within grants payable for 2024 there were restricted amounts which are to be used based upon ; Gerald Moore Foundation of £37,252 (2023 - £27,076) and £20,000 (2023 - £35,000) to be used to fund the Man Van.

The grants payable to institutions all relate to various projects carried out at Royal Surrey County Hospital and Frimley Park Hospital.

9. OTHER COSTS

Governance Costs

overnance Costs
Unrestricted Restricted Total Total
2024 2023
£ £ £ £
4,398 - 4,398 4,182
Insurance 287 - 287 -
Membership - - - 330
--------- --------- --------- ---------
Total other costs 4,685 - 4,685 4,512
===== ===== ===== =====

There were no restricted other costs in 2023.

10. EMPLOYEES

There were no employees during the period.

11. TRANSACTIONS WITH TRUSTEES

During the year no Trustees received any remuneration (2023 £Nil).

1 Trustee (2023 1) was reimbursed expenses of £546 (2023 - £1,633) for travel and fundraising event costs.

Unrestricted donations of £210 (2023- £1,040) were received from 2 (2023 3) Trustees during the year.

THE PROSTATE PROJECT NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2024

Page 20

12. CASH
Unrestricted Restricted Total Total
2024 2023
£ £ £ £
General 422,483 42,289 464,772 562,928
===== ===== ===== =====
13. CREDITORS FALLING DUE WITHIN ONE YEAR
Unrestricted Restricted Total Total
2024 2023
£ £ £ £
Grants (see note 15)
General 255,657 29,746 285,403 366,501
Accruals 20,651 - 20,651 21,199
--------- --------- --------- ---------
276,308 29,746 306,054 387,700
===== ===== ===== =====
14. CREDITORS FALLING DUE AFTER ONE YEAR
Unrestricted Restricted Total Total
2024 2023
£ £ £ £
Grants (see note 16) - - - 24,000
===== ===== ===== =====

THE PROSTATE PROJECT NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2024

Page 21

15. GRANTS PAYABLE

Funds Additional
Opening Provision Closing
Balance Payments in Year Transfers Balance
£ £ £ £
Unrestricted
SCR1
Wendy Hobby		 21,225 (19,073) 26,000 - 28,152
Immunotherapy 13,659 - - - 13,659
PGMS Administrator 23,707 (32,826) 26,000 - 16,881
Sample Collector 23,390 - - - 23,390
Research fund 5,000 (5,000) - - -
Urology 21,000 - - (21,000) -
Trainee Urologist 31,471 (68,545) 49,976 - 12,902
N Annals 36,000 (18,000) - - 18,000
Man Van 174,880 (55,733) - - 119,147
Probe 7,875 - - - 7,875
C Perna - (26,876) 32,527 - 5,651
Echolaser - (102,600) 102,600 - -
Laser - - 10,000 - 10,000
Incucyte - (11,737) 11,737 - -
--------- --------- --------- --------- ---------
Total Unrestricted 358,207 (340,390) 258,840 (21,000) 255,657
===== ===== ===== ===== =====
Funds Additional
Opening Provision Closing
Balance Payments in Year Transfers Balance
£ £ £ £
Restricted
Gerald Moore Foundation 14,971 (22,477) 37,252 - 29,746
Man Van 17,323 (37,323) 20,000 - -
--------- --------- --------- --------- ---------
Total Restricted 32,294 (59,800) 57,252 - 29,746
===== ===== ===== ===== =====
Total Funds 390,501 (400,190) 316,092 (21,000) 285,403
===== ===== ===== ===== =====
2024 2023
£ £
Creditors due within one year 285,403 366,501
Creditors due after one year - 24,000
--------- ---------
285,403 390,501
===== =====

THE PROSTATE PROJECT NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2024

Page 22

16. FUNDS

Balance at Balance at
1 July Income Resources 30 June
2023 Resources Expensed 2024
£ £ £ £
General Unrestricted Funds 138,685 282,429 (274,939) 146,175
===== ===== ===== =====
Restricted Funds
General
Gerald Moore Foundation - 37,252 (37,252) -
Immunology Fund 12,543 - - 12,543
Man Van - 20,000 (20,000) -
--------- --------- --------- ---------
Total Restricted Funds 12,543 57,252 (57,252) 12,543
===== ===== ===== =====

There are funds which have further :

Funds for the year ended 30 June 2023

Balance at Balance at
1 July Income Resources 30 June
2022 Resources Expensed 2023
£ £ £ £
General Unrestricted Funds 146,083 297,156 (304,554) 138,685
===== ===== ===== =====
Restricted Funds
General
Gerald Moore Foundation - 27,076 (27,076) -
Immunology Fund 12,543 - - 12,543
Man Van - 35,000 (35,000) -
--------- --------- --------- ---------
Total Restricted Funds 12,543 62,076 (62,076) 12,543
===== ===== ===== =====

THE PROSTATE PROJECT NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2024

Page 23

17. ANALYSIS OF NET ASSETS BETWEEN FUNDS

Grants Trade
Current Payable in Creditors and
Assets one Year Accruals Net Assets
£ £ £ £
Restricted
Immunology 12,543 - - 12,543
Gerald Moore Foundation 29,746 (29,746) - -
--------- --------- --------- ---------
42,289 (29,746) - 12,543
Unrestricted
General Fund 406,272 - (4,440) 401,832
Designated:
- PGMS Administrator 8,064 (16,881) (8,064) (16,881)
- Sample Collector - (23,390) - (23,390)
- Immunology - (13,659) - (13,659)
- SCRI
W Hobby		 - (28,152) - (28,152)
- C Perna 8,147 (5,651) (8,147) (5,651)
- Trainee Urologist - (12,902) - (12,902)
- N Annals - (18,000) - (18,000)
- Man Van - (119,147) - (119,147)
- Probe - (7,875) - (7,875)
- Laser - (10,000) - (10,000)
--------- --------- --------- ---------
422,483 (255,657) (20,651) 146,175
--------- --------- --------- ---------
Total 464,772 (285,403) (20,651) 158,718
===== ===== ===== =====

THE PROSTATE PROJECT NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2024

Page 24

17. ANALYSIS OF NET ASSETS BETWEEN FUNDS (continued)

Analysis of net assets between funds for year ended 30 June 2023

Grants Trade
Grants Payable Creditors
Current Payable in after one and Net
Assets one Year Year Accruals Assets
£ £ £ £ £
Restricted
Immunology 12,543 - - - 12,543
Gerald Moore Foundation 23,928 (14,971) - (8,957) -
Man Van 17,323 (17,323) - - -
--------- --------- --------- --------- ---------
53,794 (32,294) - (8,957) 12,543
Unrestricted
General Fund 501,332 - - (4,440) 496,892
Designated:
- PGMS Administrator 7,802 (23,707) - (7,802) (23,707)
- Sample Collector - (23,390) - - (23,390)
- Immunology - (13,659) - - (13,659)
- SCRI
W Hobby		 - (21,225) - - (21,225)
- Research Fund - (5,000) - - (5,000)
- Urology Centre - (21,000) - - (21,000)
- Trainee Urologist - (31,471) - - (31,471)
- N Annals - (12,000) (24,000) - (36,000)
- Man Van - (174,880) - - (174,880)
- Probe - (7,875) - - (7,875)
--------- --------- --------- --------- ---------
509,134 (334,207) (24,000) (12,242) 138,685
--------- --------- --------- --------- ---------
Total 562,928 (366,501) (24,000) (21,199) 151,228
===== ===== ===== ===== =====

18. CONTROLLING PARTY

The Charity has no controlling party.